Introduction: Although breast pain as a sole symptom is very rarely associated with cancer, national guidelines recommend that all women with a complaint of breast pain have to be referred for ultrasound evaluation. This study sought to investigate the necessity of this practice. Methods: A retrospective study was conducted in consecutive women aged between 17 and 39 years, at average risk of breast cancer who presented at a major tertiary breast clinic with clinically significant breast pain (unilateral, unifocal, and noncyclic) in 2017–2023. Data on background, physical examination, imaging, and pathology were collected from the electronic medical records and analyzed by outcome. Results: The cohort included 814 women. Among the 574 women (70%) with a normal physical breast examination, ultrasound revealed normal findings or BI-RADS 1–2 lesions in 499 (87%), BI-RADS 3 lesions in 59 (10%), and BI-RADS 4 lesions in 16 (3%). Biopsies, performed in 30 BI-RADS 3 lesions and all BI-RADS 4 lesions, were benign. Half of the 337 patients with available follow-up data continued to attend the breast clinic (mean 3.5 ± 2.2 years). Among the 240 women (30%) with a palpable abnormality on breast examination, ultrasound revealed normal or benign BI-RADS 2 findings in 112 (47%), BI-RADS 3 lesions in 69 (29%), and BI-RADS 4–5 lesions in 59 (25%). Biopsies performed in BI-RADS 3 lesions (12%) were all benign. Biopsies, performed in all BI-RADS 4–5 lesions, yielded malignant pathology in 16 lesions (7%) (including IDC, DCIS, or angiosarcoma). The overall breast cancer risk was 2%. Ultrasound sensitivity was 94%, specificity 85%, and negative predictive value 99%. The negative predictive value for dedicated physical examination without imaging was 100%. The biopsy-proven positive predictive value was 0 in patients with a normal breast examination compared to 18% in patients with a palpable finding on breast examination (p = 0.0017). Conclusion: A subset of women <40 years old with average breast cancer risk and breast pain, who would normally be referred for imaging, can be triaged by a dedicated physical examination. Limiting ultrasound evaluation to those with palpable findings will spare patients and the healthcare system unnecessary radiology and biopsy studies.

1.
National Comprehensive Cancer Network
.
Genetic/familial high-risk assessment: breast, ovarian, and pancreatic
. (Version 2.2024). Available from: http://www.nccn.org/professionals/physician_gls/pdf/bone.pdf (accessed March 3, 2024).
2.
Expert Panel on Breast Imaging
,
Jokich
PM
,
Bailey
L
,
D’Orsi
C
,
Green
ED
,
Holbrook
AI
,
Lee
SJ
, et al
.
ACR appropriateness Criteria® Breast Pain
.
J Am Coll Radiol
.
2017
;
14
(
5S
):
S25
33
.
3.
Chetlen
AL
,
Kapoor
MM
,
Watts
MR
.
Mastalgia: imaging work-up appropriateness
.
Acad Radiol
.
2017
;
24
(
3
):
345
9
.
4.
Komenaka
IK
,
Nodora
J
,
Martinez
ME
,
Hsu
CH
,
Wong
T
,
Shah
A
, et al
.
Mastalgia is not an indication for mammogram
.
J Am Board Fam Med
.
2022
;
12
:
jabfm.2022.AP.210476
.
5.
Arslan
M
,
Kucukerdem
HS
,
Can
H
,
Tarcan
E
.
Retrospective analysis of women with only mastalgia
.
J Breast Health
.
2016
;
12
(
4
):
151
4
.
6.
Dave
RV
,
Bromley
H
,
Taxiarchi
VP
,
Camacho
E
,
Chatterjee
S
,
Barnes
N
, et al
.
No association between breast pain and breast cancer: a prospective cohort study of 10,830 symptomatic women presenting to a breast cancer diagnostic clinic
.
Br J Gen Pract
.
2022
;
72
(
717
):
e234
43
.
7.
Zarei
F
,
Pishdad
P
,
Hatami
M
,
Zeinali-Rafsanjani
B
.
Can breast ultrasound reduce patient’s level of anxiety and pain
.
Ultrasound
.
2017
;
25
(
2
):
92
7
.
8.
American College of Radiology
.
Breast imaging reporting and data system atlas (ACR BI-RADS atlas)
. 5th ed.
Reston, VA
:
American College of Radiology
;
2013
; p.
134
6
.
9.
Expert Panel on Breast Imaging
.
Holbrook
AI
,
Moy
L
,
Akin
EA
,
Baron
P
,
Didwania
AD
, et al
.
ACR appropriateness Criteria® breast pain
.
J Am Coll Radiol
.
2018
;
15
(
11S
):
S276
82
.
10.
Owen
WA
,
Brazeal
HA
,
Shaw
HL
,
Lee
MV
,
Appleton
CM
,
Holley
SO
.
Focal breast pain: imaging evaluation and outcomes
.
Clin Imaging
.
2019
;
55
:
148
55
.
11.
Lumachi
F
,
Ermani
M
,
Brandes
AA
,
Boccagni
P
,
Polistina
F
,
Basso
SM
, et al
.
Breast complaints and risk of breast cancer: population-based study of 2,879 self-selected women and long-term follow-up
.
Biomed Pharmacother
.
2002
;
56
(
2
):
88
92
.
12.
Howard
MB
,
Battaglia
T
,
Prout
M
,
Freund
K
.
The effect of imaging on the clinical management of breast pain
.
J Gen Intern Med
.
2012
;
27
(
7
):
817
24
.
13.
Mohallem Fonseca
M
,
Lamb
LR
,
Verma
R
,
Ogunkinle
O
,
Seely
JM
.
Breast pain and cancer: should we continue to work-up isolated breast pain
.
Breast Cancer Res Treat
.
2019
;
177
(
3
):
619
27
.
14.
Noroozian
M
,
Stein
LF
,
Gaetke-Udager
K
,
Helvie
MA
.
Long-term clinical outcomes in women with breast pain in the absence of additional clinical findings: mammography remains indicated
.
Breast Cancer Res Treat
.
2015
;
149
(
2
):
417
24
.
15.
Lehman
CD
,
Lee
CI
,
Loving
VA
,
Portillo
MS
,
Peacock
S
,
DeMartini
WB
.
Accuracy and value of breast ultrasound for primary imaging evaluation of symptomatic women 30-39 years of age
.
AJR Am J Roentgenol
.
2012
;
199
(
5
):
1169
77
.
16.
Tumyan
L
,
Hoyt
AC
,
Bassett
LW
.
Negative predictive value of sonography and mammography in patients with focal breast pain
.
Breast J
.
2005
;
11
(
5
):
333
7
.
17.
Kushwaha
AC
,
Shin
K
,
Kalambo
M
,
Legha
R
,
Gerlach
KE
,
Kapoor
MM
, et al
.
Overutilization of health care resources for breast pain
.
AJR Am J Roentgenol
.
2018
;
211
(
1
):
217
23
.
18.
Mendat
CC
,
Mislan
D
,
Hession-Kunz
L
.
Patient comfort from the technologist perspective: factors to consider in mammographic imaging
.
Int J Womens Health
.
2017
;
9
:
359
64
.
19.
Brandzel
S
,
Rosenberg
DE
,
Johnson
D
,
Bush
M
,
Kerlikowske
K
,
Onega
T
, et al
.
Women’s experiences and preferences regarding breast imaging after completing breast cancer treatment
.
Patient Prefer Adherence
.
2017
;
11
:
199
204
.
20.
Barton
MB
,
Morley
DS
,
Moore
S
,
Allen
JD
,
Kleinman
KP
,
Emmons
KM
, et al
.
Decreasing women’s anxieties after abnormal mammograms: a controlled trial
.
J Natl Cancer Inst
.
2004
;
96
(
7
):
529
38
.
21.
Keyzer-Dekker
CM
,
van Esch
L
,
de Vries
J
,
Ernst
MF
,
Nieuwenhuijzen
GA
,
Roukema
JA
, et al
.
An abnormal screening mammogram causes more anxiety than a palpable lump in benign breast disease
.
Breast Cancer Res Treat
.
2012
;
134
(
1
):
253
8
.
You do not currently have access to this content.